Sold as Calcium Disodium Versenate. Every FDA application for this active ingredient: 1 branded and 1 generic.
As of Nov 16, 2026, FDA lists 2 applications for Edetate Calcium Disodium (sold as Calcium Disodium Versenate), first approved Jul 16, 1953, with 0 new uses approved and 0 published complete response letters.
| Product | Part | Spending, 2025 | Change | Beneficiaries |
|---|---|---|---|---|
| EDETATE CALCIUM DISODIUM | Part B | $1.3M | New | 59 |
| Development of a Noninvasive Metric to Measure Small Bowel Sensation - The Small Intestine Stress TestDisorders of Gut Brain Interaction · Mayo Clinic | Not applicable | Recruiting | Sep 14, 2026 |
| A Comparative Study of Normalized Residual Activity and Standard Parameters in 99mTc-DTPA Diuretic Renography:Urinary Tract Obstruction · Assiut University | — | Not yet recruiting | Sep 10, 2026 |
| Alb-PRF as an Adjunct to Regenerative Periodontal SurgeryPeriodontitis, Periodontitis Stage III · Halil Ata BIÇAKÇIOĞLU | Not applicable | Not yet recruiting | Sep 4, 2026 |
| Clinical Evaluation of Discoloration Induced by Root Canal Treatment in Vital and Devital TeethTooth Discoloration Following Root Canal Treatment, Tooth Discoloration · Marmara University | — | Active, not recruiting | Aug 24, 2026 |
| Intravenous Chelators in Lead-Burdened Type 2 Diabetic NephropathyLead-Burdened Type 2 Diabetic Nephropathy · The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Not applicable | Not yet recruiting | Jul 16, 2026 |
| Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant PeriodCirrhosis, Acute Hepatitis · Hospices Civils de Lyon | — | Not yet recruiting | Jun 15, 2026 |
| Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae InfectionsNeisseria Gonorrhoeae (Ng) Infections · Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Jun 8, 2026 |
| A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant WomenDiphtheria-Tetanus-acellular Pertussis Vaccines · GlaxoSmithKline | Phase 3 | Active, not recruiting | May 19, 2026 |
| Jul 16, 1953 | Calcium Disodium VersenateNDA 8922 · New molecular entity | Bausch | 9 | Discontinued |
| May 3, 2023 | Edetate Calcium DisodiumANDA 216435 | Casper Pharma LLC | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA